JP2008044945A - 感染症に対抗する代替医薬品としてのプロバイオティクス - Google Patents
感染症に対抗する代替医薬品としてのプロバイオティクス Download PDFInfo
- Publication number
- JP2008044945A JP2008044945A JP2007217628A JP2007217628A JP2008044945A JP 2008044945 A JP2008044945 A JP 2008044945A JP 2007217628 A JP2007217628 A JP 2007217628A JP 2007217628 A JP2007217628 A JP 2007217628A JP 2008044945 A JP2008044945 A JP 2008044945A
- Authority
- JP
- Japan
- Prior art keywords
- probiotics
- genus
- animal
- acidilactici
- infected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 60
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 60
- 208000035473 Communicable disease Diseases 0.000 title claims abstract description 4
- 208000015181 infectious disease Diseases 0.000 title claims description 17
- 239000003814 drug Substances 0.000 title description 6
- 229940079593 drug Drugs 0.000 title description 4
- 241001465754 Metazoa Species 0.000 claims abstract description 18
- 241000191998 Pediococcus acidilactici Species 0.000 claims abstract description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 10
- 241000125945 Protoparvovirus Species 0.000 claims abstract description 6
- 241000700605 Viruses Species 0.000 claims abstract description 6
- 244000045947 parasite Species 0.000 claims abstract description 5
- 241000251468 Actinopterygii Species 0.000 claims abstract description 4
- 241000186660 Lactobacillus Species 0.000 claims abstract description 4
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 4
- 244000000010 microbial pathogen Species 0.000 claims abstract description 3
- 241000287828 Gallus gallus Species 0.000 claims description 38
- 241000282472 Canis lupus familiaris Species 0.000 claims description 24
- 241000223924 Eimeria Species 0.000 claims description 18
- 241000271566 Aves Species 0.000 claims description 17
- 235000013330 chicken meat Nutrition 0.000 claims description 17
- 235000013305 food Nutrition 0.000 claims description 15
- 230000000529 probiotic effect Effects 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000028993 immune response Effects 0.000 claims description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000011888 snacks Nutrition 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 5
- 241000235070 Saccharomyces Species 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 5
- 108091007433 antigens Proteins 0.000 claims description 5
- 102000036639 antigens Human genes 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 241000192001 Pediococcus Species 0.000 claims description 4
- 230000035755 proliferation Effects 0.000 claims description 4
- 241000186000 Bifidobacterium Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 241000282412 Homo Species 0.000 claims description 3
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 241000242722 Cestoda Species 0.000 claims description 2
- 241000194033 Enterococcus Species 0.000 claims description 2
- 241000224466 Giardia Species 0.000 claims description 2
- 241000244206 Nematoda Species 0.000 claims description 2
- 241000702670 Rotavirus Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 244000000013 helminth Species 0.000 claims description 2
- 239000004278 EU approved seasoning Substances 0.000 claims 2
- 235000014048 cultured milk product Nutrition 0.000 claims 2
- 235000011194 food seasoning agent Nutrition 0.000 claims 2
- 235000013618 yogurt Nutrition 0.000 claims 2
- 241000272525 Anas platyrhynchos Species 0.000 claims 1
- 241000272517 Anseriformes Species 0.000 claims 1
- 241000726096 Aratinga Species 0.000 claims 1
- 241000700198 Cavia Species 0.000 claims 1
- 241000282693 Cercopithecidae Species 0.000 claims 1
- 241000272201 Columbiformes Species 0.000 claims 1
- 241000699800 Cricetinae Species 0.000 claims 1
- 241000223935 Cryptosporidium Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241000222722 Leishmania <genus> Species 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 241000282579 Pan Species 0.000 claims 1
- 241000286209 Phasianidae Species 0.000 claims 1
- 241000224016 Plasmodium Species 0.000 claims 1
- 241000287530 Psittaciformes Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 241000223996 Toxoplasma Species 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 12
- 208000003495 Coccidiosis Diseases 0.000 abstract description 3
- 206010023076 Isosporiasis Diseases 0.000 abstract description 3
- 230000007969 cellular immunity Effects 0.000 abstract description 2
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 210000003250 oocyst Anatomy 0.000 description 16
- 239000000203 mixture Substances 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 8
- 108010062580 Concanavalin A Proteins 0.000 description 7
- 241000223931 Eimeria acervulina Species 0.000 description 7
- 210000003608 fece Anatomy 0.000 description 7
- 208000018522 Gastrointestinal disease Diseases 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000001079 digestive effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000035861 hematochezia Diseases 0.000 description 6
- 241000223932 Eimeria tenella Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 210000004988 splenocyte Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000027503 bloody stool Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 208000030852 Parasitic disease Diseases 0.000 description 3
- 230000024932 T cell mediated immunity Effects 0.000 description 3
- 230000005875 antibody response Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000012447 hatching Effects 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000008071 Parvoviridae Infections Diseases 0.000 description 2
- 206010057343 Parvovirus infection Diseases 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 210000004215 spore Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- -1 Metronazole Chemical compound 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940126675 alternative medicines Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000007236 host immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009696 proliferative response Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940080693 reglan Drugs 0.000 description 1
- 229960002181 saccharomyces boulardii Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Images
Classifications
-
- Y02A50/49—
-
- Y02A50/491—
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/493,859 US7935334B2 (en) | 2005-07-07 | 2006-07-26 | Probiotics as alternative medicines against infectious diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008044945A true JP2008044945A (ja) | 2008-02-28 |
| JP2008044945A5 JP2008044945A5 (https=) | 2010-09-30 |
Family
ID=39179015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007217628A Pending JP2008044945A (ja) | 2006-07-26 | 2007-07-26 | 感染症に対抗する代替医薬品としてのプロバイオティクス |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2008044945A (https=) |
| CN (1) | CN101172118A (https=) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010024413A1 (ja) | 2008-08-29 | 2010-03-04 | 明治飼糧株式会社 | 抗コクシジウム組成物 |
| KR20140051279A (ko) * | 2011-08-03 | 2014-04-30 | 그노시스 에스.피.에이. | 비만을 조절하기 위해 사카로마이세스 보울라디 및 수퍼옥시드 디스뮤타제를 함유하는 제제 |
| KR101802447B1 (ko) * | 2016-06-21 | 2017-11-30 | 주식회사 카브 | 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물 |
| KR20180041400A (ko) * | 2016-10-14 | 2018-04-24 | 한국식품연구원 | 락토바실러스 사케이 k040706을 함유하는 바이러스 감염 질환 예방 또는 치료용 조성물 |
| WO2020067368A1 (ja) * | 2018-09-26 | 2020-04-02 | 株式会社明治 | ミトコンドリア機能改善剤 |
| JP2021075489A (ja) * | 2019-11-11 | 2021-05-20 | 株式会社カワシマ | 感染症の予防及び治療をするための複合土壌菌製剤 |
| CN114015598A (zh) * | 2021-11-05 | 2022-02-08 | 吉林农业大学 | 分离自藏灵菇的乳酸片球菌及其在防治轮状病毒感染中的应用 |
| JP2023514200A (ja) * | 2020-02-11 | 2023-04-05 | ローカス アイピー カンパニー リミテッド ライアビリティ カンパニー | 家畜において有害な腸内大気ガスを減少させるための方法および組成物 |
| JP2024110378A (ja) * | 2023-02-02 | 2024-08-15 | 葡萄王生技股▲ふん▼有限公司 | 腎機能障害を予防または治療するための組成物の製造におけるペディオコッカス・アシディラクティシｇｋａ４の使用 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2546330B1 (en) * | 2010-03-10 | 2015-08-19 | Kaneka Corporation | Lactic acid bacterium-containing preparation |
| BR112013002685A2 (pt) * | 2010-08-03 | 2016-05-31 | Hills Pet Nutrition Inc | composições alimentícias para animais de estimação apresentando atividade antimicrobiana |
| CN102224885B (zh) * | 2011-05-24 | 2013-04-03 | 上海创博现代自然农业（集团）有限公司 | 一种育肥猪用液体诱食剂的生产方法 |
| RU2015103826A (ru) * | 2012-07-05 | 2016-08-27 | Сентро Насиональ Де Текнолохия И Сегуридад Алиментария, Лабораторио Дель Эбро | Микрочастица (варианты), ее включающая композиция (варианты), пищевой, фармацевтический, лечебный косметический или нутрицевтический продукт на их основе, способ приготовления иммуномодулирующей композиции с их помощью и способ получения указанной микрочастицы |
| CN103947825B (zh) * | 2014-03-28 | 2016-03-30 | 甘肃富民生态农业科技有限公司 | 一种宠物饲料添加剂及其生产方法 |
| CN105597054A (zh) * | 2016-01-06 | 2016-05-25 | 崔仲恩 | 一种预防大约克夏猪绦虫病的组合物及其制备方法 |
| CN106578587A (zh) * | 2016-12-29 | 2017-04-26 | 柳州市讯丰养殖有限公司 | 一种乳鸽防病饲料及其制作方法 |
| CN106577543A (zh) * | 2016-12-29 | 2017-04-26 | 柳州市讯丰养殖有限公司 | 一种防病的乳鸽养殖方法 |
| CN107897514A (zh) * | 2017-12-27 | 2018-04-13 | 江南大学 | 一种复合型无抗生物饲料添加剂 |
| CN108935970A (zh) * | 2018-09-06 | 2018-12-07 | 青岛康尔生物工程有限公司 | 一种含壳寡糖的无抗饲料功能产品、其制备方法及应用 |
| CN113142383B (zh) * | 2021-04-09 | 2022-10-25 | 凯恩格生物科技(宜昌)有限公司 | 一种复合微生物添加剂及其在宠物饲料中的应用 |
| CN117467581B (zh) * | 2023-12-22 | 2024-03-08 | 山东威曼宠物食品有限公司 | 一种提高犬免疫力的乳酸片球菌King73及其应用 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004523241A (ja) * | 2001-03-07 | 2004-08-05 | プロバイオニック コーポレイション | プロバイオティクスとして有用な新規ラクトバチルス・ロイテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ） |
| WO2005047489A1 (en) * | 2003-11-07 | 2005-05-26 | The Procter & Gamble Company | Stabilized compositions comprising probiotics |
| US20050186188A1 (en) * | 2004-02-19 | 2005-08-25 | Peilin Guo | Compositions containing probiotics and polysaccharides and methods of use |
| WO2006000992A1 (en) * | 2004-06-23 | 2006-01-05 | L'oreal | Method and compositions useful for preventing and/or treating sensitive and/or dry skin |
| US20060008511A1 (en) * | 2004-07-08 | 2006-01-12 | Jhy-Jhu Lin | Probiotic products for pet applications |
| WO2006133472A1 (de) * | 2005-06-14 | 2006-12-21 | Erber Aktiengesellschaft | Probiotischer, gesundheits- bzw. lei stungs fördernder nahrungs-, futtermittel und/oder trinkwasserzusatz sowie seine verwendung |
-
2007
- 2007-07-25 CN CNA2007101398783A patent/CN101172118A/zh active Pending
- 2007-07-26 JP JP2007217628A patent/JP2008044945A/ja active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004523241A (ja) * | 2001-03-07 | 2004-08-05 | プロバイオニック コーポレイション | プロバイオティクスとして有用な新規ラクトバチルス・ロイテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ） |
| WO2005047489A1 (en) * | 2003-11-07 | 2005-05-26 | The Procter & Gamble Company | Stabilized compositions comprising probiotics |
| US20050186188A1 (en) * | 2004-02-19 | 2005-08-25 | Peilin Guo | Compositions containing probiotics and polysaccharides and methods of use |
| WO2006000992A1 (en) * | 2004-06-23 | 2006-01-05 | L'oreal | Method and compositions useful for preventing and/or treating sensitive and/or dry skin |
| US20060008511A1 (en) * | 2004-07-08 | 2006-01-12 | Jhy-Jhu Lin | Probiotic products for pet applications |
| WO2006133472A1 (de) * | 2005-06-14 | 2006-12-21 | Erber Aktiengesellschaft | Probiotischer, gesundheits- bzw. lei stungs fördernder nahrungs-, futtermittel und/oder trinkwasserzusatz sowie seine verwendung |
Non-Patent Citations (2)
| Title |
|---|
| JPN6012063965; Ｊ． Ａｐｐｌ． Ｍｉｃｒｏｂｉｏｌｏｇｙ， ２０００， Ｖｏｌ．８９， Ｎｏ．３， ｐｐ．４０４-４１４ * |
| JPN6012063967; Ｊ． Ｍｅｄ． Ｍｉｃｒｏｂｉｏｌ．， １９９８， Ｖｏｌ．４７， Ｎｏ．２， ｐｐ．１１１-１１６ * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010024413A1 (ja) | 2008-08-29 | 2010-03-04 | 明治飼糧株式会社 | 抗コクシジウム組成物 |
| KR20140051279A (ko) * | 2011-08-03 | 2014-04-30 | 그노시스 에스.피.에이. | 비만을 조절하기 위해 사카로마이세스 보울라디 및 수퍼옥시드 디스뮤타제를 함유하는 제제 |
| KR101954674B1 (ko) | 2011-08-03 | 2019-03-06 | 그노시스 에스.피.에이. | 비만을 조절하기 위해 사카로마이세스 보울라디 및 수퍼옥시드 디스뮤타제를 함유하는 제제 |
| KR101802447B1 (ko) * | 2016-06-21 | 2017-11-30 | 주식회사 카브 | 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물 |
| WO2017222295A1 (ko) * | 2016-06-21 | 2017-12-28 | 주식회사 카브 | 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물 |
| KR20180041400A (ko) * | 2016-10-14 | 2018-04-24 | 한국식품연구원 | 락토바실러스 사케이 k040706을 함유하는 바이러스 감염 질환 예방 또는 치료용 조성물 |
| KR102143608B1 (ko) | 2016-10-14 | 2020-08-11 | 한국식품연구원 | 락토바실러스 사케이 k040706을 함유하는 바이러스 감염 질환 예방 또는 치료용 조성물 |
| JP7498455B2 (ja) | 2018-09-26 | 2024-06-12 | 株式会社明治 | ミトコンドリア機能改善剤 |
| WO2020067368A1 (ja) * | 2018-09-26 | 2020-04-02 | 株式会社明治 | ミトコンドリア機能改善剤 |
| JPWO2020067368A1 (ja) * | 2018-09-26 | 2021-08-30 | 株式会社明治 | ミトコンドリア機能改善剤 |
| US12083152B2 (en) | 2018-09-26 | 2024-09-10 | Meiji Co., Ltd. | Agent for improving mitochondrial function |
| JP2021075489A (ja) * | 2019-11-11 | 2021-05-20 | 株式会社カワシマ | 感染症の予防及び治療をするための複合土壌菌製剤 |
| JP2023514200A (ja) * | 2020-02-11 | 2023-04-05 | ローカス アイピー カンパニー リミテッド ライアビリティ カンパニー | 家畜において有害な腸内大気ガスを減少させるための方法および組成物 |
| CN114015598B (zh) * | 2021-11-05 | 2022-10-18 | 吉林农业大学 | 分离自藏灵菇的乳酸片球菌及其在防治轮状病毒感染中的应用 |
| CN114015598A (zh) * | 2021-11-05 | 2022-02-08 | 吉林农业大学 | 分离自藏灵菇的乳酸片球菌及其在防治轮状病毒感染中的应用 |
| JP2024110378A (ja) * | 2023-02-02 | 2024-08-15 | 葡萄王生技股▲ふん▼有限公司 | 腎機能障害を予防または治療するための組成物の製造におけるペディオコッカス・アシディラクティシｇｋａ４の使用 |
| JP7553634B2 (ja) | 2023-02-02 | 2024-09-18 | 葡萄王生技股▲ふん▼有限公司 | 腎機能障害を予防または治療するための組成物の製造におけるペディオコッカス・アシディラクティシｇｋａ４の使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101172118A (zh) | 2008-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008044945A (ja) | 感染症に対抗する代替医薬品としてのプロバイオティクス | |
| US7935334B2 (en) | Probiotics as alternative medicines against infectious diseases | |
| Arif et al. | The biodegradation role of Saccharomyces cerevisiae against harmful effects of mycotoxin contaminated diets on broiler performance, immunity status, and carcass characteristics | |
| Apata | Growth performance, nutrient digestibility and immune response of broiler chicks fed diets supplemented with a culture of Lactobacillus bulgaricus | |
| Lutful Kabir | The role of probiotics in the poultry industry | |
| US11203625B2 (en) | Compositions including different types of transfer factor | |
| JP4584577B2 (ja) | コクシジウムの制御のための方法および組成物 | |
| Śmiałek et al. | The use of probiotics in the reduction of Campylobacter spp. prevalence in poultry | |
| Ripon et al. | Dose-dependent response to phytobiotic supplementation in feed on growth, hematology, intestinal pH, and gut bacterial load in broiler chicken | |
| CN106795482B (zh) | 允许在营养不良的情况下促进人和动物的幼年生长的乳杆菌组合物 | |
| Khan et al. | Effect of vitamins, protein level and probiotics on immune response of moulted male broiler breeders | |
| Abd El-Aziz et al. | Fructooligosaccharide supplementation boosts growth performance, antioxidant status, and cecal microbiota differently in two rabbit breeds | |
| Sheikhzadeh et al. | Can heat‐killed Gordonia bronchialis enhance growth and immunity in rainbow trout (Oncorhynchus mykiss)? | |
| Aruwa et al. | Interplay of poultry–microbiome interactions–influencing factors and microbes in poultry infections and metabolic disorders | |
| Jin et al. | Effect of microencapsulation of egg yolk immunoglobulin Y by sodium alginate/chitosan/sodium alginate on the growth performance, serum parameters, and intestinal health of broiler chickens | |
| Kane et al. | Influence of probiotic, Lactobacillus plantarum on serum biochemical and immune parameters in vaccinated rainbow trout (Oncorhynchus mykiss) against streptococcosis/lactococosis | |
| Naguib et al. | Comparative effectiveness of various multi-antigen vaccines in controlling Campylobacter jejuni in Broiler chickens | |
| White et al. | Hatchery and dietary application of synbiotics in broilers: performance and mRNA abundance of ileum tight junction proteins, nutrient transporters, and immune response markers | |
| JP7092785B2 (ja) | 飼料添加物製剤ならびにその製造方法および使用方法 | |
| Bryan et al. | The influence of indigestible protein on broiler digestive tract morphology and caecal protein fermentation metabolites | |
| Kőrösi Molnár et al. | Effect of different concentrations of Bacillus subtilis on immune response of broiler chickens | |
| Al-Aqaby et al. | Effectiveness of using probiotic Batcinel-K® and CEVAC SET-K® vaccine on some blood parameters in chickens | |
| JP2007538090A (ja) | 伝達因子封入組成物および使用方法 | |
| CN101074260A (zh) | 嗜水气单胞菌主要保护性抗原单价、多价卵黄抗体的制备方法,及在水产动物上的应用 | |
| Nazir et al. | Influence of dietary supplementation with yeast culture and microencapsulated butyric acid on growth performance, carcass traits, gut health, and immune status in broilers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100726 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100726 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121211 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130507 |